O
Olivier Elemento
Researcher at Cornell University
Publications - 596
Citations - 38936
Olivier Elemento is an academic researcher from Cornell University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 82, co-authored 471 publications receiving 27739 citations. Previous affiliations of Olivier Elemento include Princeton University & Max Planck Society.
Papers
More filters
Journal ArticleDOI
Assessing human blastocyst quality using artificial intelligence (AI) convolutional neural network (CNN)
Nikica Zaninovic,Pegah Khosravi,Iman Hajirasouliha,Jonas Malmsten,Ehsan Kazemi,Qiansheng Zhan,M. Toschi,Olivier Elemento,Zev Rosenwaks +8 more
Book ChapterDOI
Computational methods in tumor immunology.
TL;DR: This chapter describes numerous such computational approaches in tumor immunology that leverage high-throughput data from diverse sources to systematically interrogate tumor immunity in context of its microenvironment, and to identify mechanisms that confer resistance or sensitivity to cancer therapies, in particular immunotherapy.
Journal ArticleDOI
Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer.
Michael Karass,Rohan Bareja,Ethan Shelkey,Panagiotis J. Vlachostergios,Brian D. Robinson,Francesca Khani,Juan Miguel Mosquera,Douglas S. Scherr,Andrea Sboner,Scott T. Tagawa,Ana M. Molina,Olivier Elemento,David M. Nanus,Bishoy Faltas,Bishoy Faltas +14 more
TL;DR: Findings show that oncogenic addiction to ERBB2 signaling potentially predicts response to ER BB2-directed therapy of UC.
Journal ArticleDOI
Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome
Kyung Park,Hung Tran,Kenneth Eng,Kenneth Eng,Sinan Ramazanoglu,Sinan Ramazanoglu,Rebecca M Marrero Rolon,Theresa Scognamiglio,Alain C. Borczuk,Juan Miguel Mosquera,Juan Miguel Mosquera,Qiulu Pan,Qiulu Pan,Andrea Sboner,Andrea Sboner,Mark A. Rubin,Mark A. Rubin,Olivier Elemento,Olivier Elemento,Hanna Rennert,Helen Fernandes,Wei Song,Wei Song +22 more
TL;DR: This study serves as an example for validating a comprehensive targeted next-generation sequencing assay with both DNASeq and RNASeq components for New York State-Department of Health guidelines for the Oncomine Comprehensive Panel v2.
Journal ArticleDOI
Targeting the Epichaperome As an Effective Precision Medicine Approach in a Novel PML-SYK Fusion Acute Myeloid Leukemia
Gail J. Roboz,Mayumi Sugita,Juan Miguel Mosquera,David Wilkes,Sarah Nataraj,Reyna A. Jimenez-Flores,Rohan Bareja,LunBiao Yan,Kenneth Eng,Jaclyn A. Croyle,Theresa Y. MacDonald,Zohal Noorzad,Danielle Pancirer,Shuhua Cheng,Jenny Xiang,Luke C. Olson,David S. Rickman,Wayne Tam,Mark A. Rubin,Himisha Beltran,Andrea Sboner,Koen van Besien,Bob Morgan,Duane C. Hassane,Olivier Elemento,Gabriela Chiosis,Monica L. Guzman +26 more
TL;DR: A novel flow cytometry-based PU-FITC binding assay to evaluate epichaperome levels at the single cell level successfully identified a patient predicted to respond to treatment with PU-H71, a poor prognosis AML patient who had relapsed after allogeneic stem cell transplantation.